These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11464179)

  • 1. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.
    Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
    J Am Acad Dermatol; 2001 Aug; 45(2):187-95. PubMed ID: 11464179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
    Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
    J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
    DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
    J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
    Webster GF; Leyden JJ; Gross JA
    J Drugs Dermatol; 2014 Jun; 13(6):665-70. PubMed ID: 24918555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne.
    Del Rosso JQ; Kircik L
    J Drugs Dermatol; 2024 Jun; 23(6):423-428. PubMed ID: 38834211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris.
    Kus S; Gün D; Demirçay Z; Sur H
    Int J Dermatol; 2005 Mar; 44(3):248-51. PubMed ID: 15807739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acne with intermittent isotretinoin.
    Goulden V; Clark SM; McGeown C; Cunliffe WJ
    Br J Dermatol; 1997 Jul; 137(1):106-8. PubMed ID: 9274635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
    Agarwal US; Besarwal RK; Bhola K
    Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial.
    Strauss JS; Gottlieb AB; Jones T; Koo JY; Leyden JJ; Lucky A; Pappas AA; McLane J; Leach EE
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):777-84. PubMed ID: 11050580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.